New studies into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are showing encouraging results in treating weight gain and diabetes non-insulin-dependent diabetes. Initial data suggest a novel process https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/